Lara M Groetzinger Selected Research

Catheters

9/2018

Apixaban or Rivaroxaban Versus Warfarin for Treatment of Submassive Pulmonary Embolism After Catheter-Directed Thrombolysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lara M Groetzinger Research Topics

Disease

2	Acute Kidney Injury (Acute Renal Failure) 01/2023 - 01/2023
2	Critical Illness (Critically Ill) 01/2021 - 01/2018
1	Septic Shock (Toxic Shock Syndrome) 11/2023
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 12/2021
1	Paralysis (Palsy) 01/2021
1	Coma (Comas) 01/2021
1	Heart Arrest (Cardiac Arrest) 01/2021
1	Multiple Organ Failure (MODS) 01/2021
1	Delirium 12/2020
1	Chronic Renal Insufficiency 01/2019
1	Pulmonary Embolism 09/2018
1	Drug-Related Side Effects and Adverse Reactions 01/2018

Drug/Important Bio-Agent (IBA)

2	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2023
2	Warfarin (Coumadin)FDA LinkGeneric 01/2019 - 09/2018
2	apixabanIBA 01/2019 - 09/2018
1	cisatracurium (Nimbex)FDA Link 12/2021
1	Rocuronium (Zemuron)FDA LinkGeneric 01/2021
1	BenzodiazepinesIBA 01/2021
1	Factor Xa InhibitorsIBA 09/2018
1	AnticoagulantsIBA 09/2018
1	RivaroxabanIBA 09/2018
1	Ketamine FDA LinkGeneric 01/2018
1	Hypnotics and Sedatives (Sedatives)IBA 01/2018

Therapy/Procedure

1	Therapeutics 11/2023
1	Length of Stay 12/2020
1	Artificial Respiration (Mechanical Ventilation) 12/2020
1	Catheters 09/2018